Search Within

Joachim Yahalom

  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (88)
  2. Journal Article (60)
  3. Conference Paper (3)
  4. Book Section (2)
  5. Correspondence (2)
  6. Editorial (2)
  7. Guidelines (2)
  8. Review (2)
Groups
  1. Radiation Oncology, Department of (161)
  2. Survivorship Research (161)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (48)
  5. Center for Hematologic Malignancies (40)
  6. Graduate Medical Education (37)

More Groups

People
  1. Brandon Imber (38)
  2. Carla Hajj (25)
  3. Kathryn Tringale (17)
  4. Beatrice Fregonese (16)
  5. Neil Wijetunga (15)
  6. Michael Scordo (14)

More People

Years
  1. 2025 (2)
  2. 2024 (11)
  3. 2023 (9)
  4. 2022 (11)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (125)
  2. Radiotherapy and Oncology (11)
  3. Biology of Blood and Marrow Transplantation (4)
  4. Clinical Lymphoma, Myeloma and Leukemia (4)
  5. Seminars in Radiation Oncology (4)
  6. Hematology/Oncology Clinics of North America (3)

More Publications

Publishers
  1. Elsevier Inc. (161)

Results (161)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consolidation regimen and cerebral atrophy in patients with primary central nervous system lymphoma
    Journal Article

    Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A. S.; Yahalom, J.; Cederquist, G. Y.; Schaff, L. R.; Hatzoglou, V.; Young, R. J.; Payinkay, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal
    Review

    Cederquist, G. Y.; Tringale, K.; Yahalom, J.; Imber, B. S.
    Seminars in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Normalization oflactate dehydrogenase (LDH) as a potential prognostic factor for relapsed/refractory aggressive B-cell lymphoma (R/R BCL) patients receiving car t following bridging radiotherapy: Results from a multi-institutional ILROG CAR T consortium
    Meeting Abstract

    Chelius, M.; Yegya-Raman, N.; Baron, J.; Jain, M. D.; Yahalom, J.; Imber, B. S.; Dandapani, S. V.; Ladbury, C. J.; Fang, P.; Wu, S. Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Associations between genetic alterations in follicular lymphoma and radiosensitivity
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Chan, A.; Lee, J.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H. G.; Ma, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • The association of consolidation strategies with cerebral atrophy in primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A.; Yahalom, J.; Cederquist, G.; Schaff, L.; Young, R. J.; Hatzoglou, V.; Payinkay, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Early experience with salvage RT for relapsed / refractory multiple myeloma following BCMA-directed CART cell therapy
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Mailankody, S.; Usmani, S.; Imber, B. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Failure patterns by PET for relapsed / refractory Multiple Myeloma (r/r MM) after CART cell therapy: Potential role for radiotherapy (RT)?
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Hubbeling, H. G.; Mailankody, S.; Usmani, S.; Yahalom, J.; Imber, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Radiation therapy (RT) in a new era of Multiple Myeloma (MM) therapy: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Cederquist, G.; Usmani, S.; Imber, B. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save